Roles of Smurf1 in Cbfa1 Degradation and Bone Formation

Smurf1 在 Cbfa1 降解和骨形成中的作用

• 批准号: 7392312
• 负责人: DI CHEN
• 金额: $ 25.26万
• 依托单位: UNIVERSITY OF ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-06-21 至 2010-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7392312
• 关键词: Adult; Animals; Binding; Bone Development; Bone Growth; Bone Resorption; Bone remodeling; Cells; Collagen Type I; Complex; Data; Degradation Pathway; Deterioration; Development; Disease; Dominant-Negative Mutation; Elderly; Embryonic Development; Equilibrium; Family; Fibrinogen; Gene Targeting; Genetic Transcription; Growth; In Vitro; Lead; Life; Living Wills; Mediating; Metabolic Bone Diseases; Molecular; Molecular Target; Mus; Osteoblasts; Osteogenesis; Osteoporosis; Pathogenesis; Pathway interactions; Phosphorylation; Physiological; Play; Postmenopause; Process; Proteins; Proteomics; Public Health; Rate; Receptor Serine/Threonine Kinase; Regulation; Reporting; Role; Signal Pathway; Signal Transduction; Signaling Molecule; Staging; System; Testing; Time; Tissues; Transgenes; Transgenic Mice; Ubiquitin; Ubiquitination; Woman; Work; bone; bone loss; bone morphogenetic protein 2; bone turnover; drug development; in vivo; inhibitor/antagonist; member; multicatalytic endopeptidase complex; mutant; postnatal; precursor cell; promoter; protein degradation; protein function; response; transcription factor; transgene expression; ubiquitin-protein ligase

DESCRIPTION (provided by applicant): Osteoporosis is a metabolic bone disease characterized by low bone mass and deterioration of bone microarchitecture. An understanding of the mechanisms by which bone formation is controlled is critical to understanding the pathogenesis of osteoporosis and defining molecular targets for development of new therapies for the treatment of this debilitating disease. Several lines of evidence show that BMP signaling plays a critical role in bone formation in vivo. A major mechanism by which BMPs stimulate osteoblast differentiation is by activation of the bone-specific transcription factor Cbfa1 through its downstream signaling molecules, Smad1 and 5. Recently we have discovered for the first time that inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. We also identified for the first time that the E3 ubiquitin ligase Smurf1 mediates Cbfa1 degradation in an ubiquitin-proteasome-dependent manner. The detailed molecular mechanisms by which Smurf1 mediates Cbfa1 degradation and the regulatory role of Smurf1 in bone formation in vivo remain undefined. In the proposed studies, we will determine the mechanisms by which Smurf1 mediates Cbfa1 degradation and the role of Smurf1 in bone formation in vivo. The underlying hypothesis is that Smurf1 is an important regulatory molecule for Smad1 and Cbfa1 function and plays a critical role in regulation of bone formation in vivo. In Specific Aim 1, we will determine whether Smurf1-mediated Cbfa1 degradation is dependent on activation of BMP signaling, phosphorylation of Smad1 and formation of a Smad1/Cbfa1 protein complex. We will also determine whether PTH induces Cbfa1 degradation and the effects of Smurf1 on PTH-induced Cbfa1 degradation. In Specific Aim 2, we will determine the effects of over-expression of wild-type and mutant Smurf1 on bone formation in intact and ovariectomized animals and osteoblast function and protein levels of Smad1 and Cbfa1 in Smurf1 transgenic mice. We will also determine the effects of bone growth regulatory factors on bone formation in Smurf1 transgenic mice. To investigate the specific role of Smurf1 in bone formation during specific developmental stages, such as postnatal and adult life, we will also generate tissue-specific transgenic mice in which transgene expression is inducible. Our working hypotheses are that (1) Smurf1-mediated Cbfa1 degradation is dependent on activation of BMP signaling; (2) Modulation of osteoblast Smurf1 activity in vivo will result in abnormalities in bone formation that cannot be compensated for by other members of the E3 ubiquitin ligase family; and (3) Smurf1 regulates bone formation in both postnatal and adult life. The proposed studies will lead to a better understanding of the molecular mechanisms by which Smurf1 mediates Cbfa1 degradation and the physiological role of Smurf1 in bone formation in vivo. This study will also help identify a new molecular target for drug development for the treatment of osteoporosis and other bone-loss associated diseases.

描述（由申请人提供）：骨质疏松症是一种代谢性骨病，其特征为骨量降低和骨微结构恶化。了解控制骨形成的机制对于了解骨质疏松症的发病机制和确定用于治疗这种使人衰弱的疾病的新疗法的分子靶点至关重要。几条证据表明，BMP信号传导在体内骨形成中起关键作用。BMP刺激成骨细胞分化的一个主要机制是通过激活骨特异性转录因子Cbfa 1通过其下游信号分子Smad 1和5。最近，我们首次发现成骨细胞蛋白酶体抑制剂在体内和体外刺激骨形成。我们还首次发现E3泛素连接酶Smurf 1以泛素-蛋白酶体依赖的方式介导Cbfa 1降解。Smurf 1介导Cbfa 1降解的详细分子机制以及Smurf 1在体内骨形成中的调节作用仍不清楚。 在拟议的研究中，我们将确定Smurf 1介导Cbfa 1降解的机制以及Smurf 1在体内骨形成中的作用。潜在的假设是Smurf 1是Smad 1和Cbfa 1功能的重要调节分子，在体内骨形成的调节中起着关键作用。在特定目标1中，我们将确定Smurf 1介导的Cbfa 1降解是否依赖于BMP信号传导的激活、Smad 1的磷酸化和Smad 1/Cbfa 1蛋白复合物的形成。我们还将确定PTH是否诱导Cbfa 1降解以及Smurf 1对PTH诱导的Cbfa 1降解的影响。在具体目标2中，我们将确定野生型和突变型Smurf 1的过表达对完整和卵巢切除动物骨形成的影响，以及Smurf 1转基因小鼠中Smad 1和Cbfa 1的成骨细胞功能和蛋白水平。我们还将确定骨生长调节因子对Smurf 1转基因小鼠骨形成的影响。为了研究Smurf 1在特定发育阶段（如出生后和成年）骨形成中的特定作用，我们还将产生组织特异性转基因小鼠，其中转基因表达是可诱导的。我们的工作假设是：（1）Smurf 1介导的Cbfa 1降解依赖于BMP信号的激活;（2）体内成骨细胞Smurf 1活性的调节将导致骨形成的异常，而E3泛素连接酶家族的其他成员无法补偿;（3）Smurf 1在出生后和成年期都调节骨形成。拟议的研究将导致更好地了解Smurf 1介导Cbfa 1降解的分子机制以及Smurf 1在体内骨形成中的生理作用。这项研究还将有助于确定一个新的分子靶点，用于治疗骨质疏松症和其他骨丢失相关疾病的药物开发。

项目成果

MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation.

• DOI: 10.1002/stem.288
• 发表时间: 2010-02
• 期刊: STEM CELLS
• 影响因子: 5.2
• 作者: Huang, Jian;Zhao, Lan;Xing, Lianping;Chen, Di
• 通讯作者: Chen, Di

Osthole stimulates osteoblast differentiation and bone formation by activation of beta-catenin-BMP signaling.

oSthole通过激活β-catenin-BMP信号传导刺激成骨细胞分化和骨形成。

• DOI: 10.1002/jbmr.21
• 发表时间: 2010-06
• 期刊: JOURNAL OF BONE AND MINERAL RESEARCH
• 影响因子: 6.2
• 作者: Tang, De-Zhi;Hou, Wei;Zhou, Quan;Zhang, Minjie;Holz, Jonathan;Sheu, Tzong-Jen;Li, Tian-Fang;Cheng, Shao-Dan;Shi, Qi;Harris, Stephen E.;Chen, Di;Wang, Yong-Jun
• 通讯作者: Wang, Yong-Jun

Generation of Axin1 conditional mutant mice.

• DOI: 10.1002/dvg.20703
• 发表时间: 2011-02
• 期刊: GENESIS
• 影响因子: 1.5
• 作者: Xie, Rong;Jiang, Rulang;Chen, Di
• 通讯作者: Chen, Di

BMP-2 modulates beta-catenin signaling through stimulation of Lrp5 expression and inhibition of beta-TrCP expression in osteoblasts.

• DOI: 10.1002/jcb.22319
• 发表时间: 2009-11-01
• 期刊: JOURNAL OF CELLULAR BIOCHEMISTRY
• 影响因子: 4
• 作者: Zhang, Ming;Yan, Ying;Lim, Yong-bin;Tang, Dezhi;Xie, Rong;Chen, Ann;Tai, Peter;Harris, Stephen E.;Xing, Lianping;Qin, Yi-Xian;Chen, Di
• 通讯作者: Chen, Di

Smurf control in bone cells.

• DOI: 10.1002/jcb.22586
• 发表时间: 2010-06-01
• 期刊: JOURNAL OF CELLULAR BIOCHEMISTRY
• 影响因子: 4
• 作者: Xing, Lianping;Zhang, Ming;Chen, Di
• 通讯作者: Chen, Di